Affordable Access

Access to the full text

Maternal age-specific risk for trisomy 21 based on the clinical performance of NIPT and empirically derived NIPT age-specific positive and negative predictive values in Japan

Authors
  • Yamada, Takahiro
  • Sekizawa, Akihiko
  • Fujii, Yosuke
  • Hirose, Tatsuko
  • Samura, Osamu
  • Suzumori, Nobuhiro
  • Miura, Kiyonori
  • Sawai, Hideaki
  • Hirahara, Fumiki
  • Murotsuki, Jun
  • Kamei, Yoshimasa
  • Sago, Haruhiko
Type
Published Article
Journal
Journal of Human Genetics
Publisher
Springer Nature
Publication Date
May 30, 2018
Volume
63
Issue
10
Pages
1035–1040
Identifiers
DOI: 10.1038/s10038-018-0453-8
Source
Springer Nature
License
Yellow

Abstract

The data collected by nation-wide study of noninvasive prenatal genetic testing (NIPT) for trisomy 21 from 21,610 pregnant women with advanced maternal age in Japan were reported. Among 188 NIPT-positive cases, 180 cases were true positive. The incidence of aneuploidy according to maternal age was estimated using a state-space model. Although, the frequency of trisomy increased exponentially with maternal age as previously reported, the maternal age-specific risk for trisomy 21 that was based on the clinical performance of NIPT was lower than the predicted risk in previous Western cohorts based on the data from invasive prenatal testing (Bayesian two-sided tail-area probability P = 0.0156). The empirical positive predictive value (PPV) of NIPT is likely to turn out higher than that of the theoretical PPV calculated from the sensitivity/specificity of the test and the incidence of trisomy 21 from this study.

Report this publication

Statistics

Seen <100 times